Including the quality-of-life effects in the evaluation of prostate cancer screening: Expert opinions revisited?

BJU International, Supplement

Volumn 92, Issue 2, 2003, Pages 101-105

  Essink Bot, M L ^a   Korfage, I J ^a   De Koning, H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cost utility analysis; Health status; Prostate cancer; Prostate cancer screening; Quality of life

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURVIVAL; COST UTILITY ANALYSIS; EMPIRICISM; FOLLOW UP; HEALTH STATUS; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZATION; SEXUAL DYSFUNCTION; URINARY DYSFUNCTION;

AGED; COST-BENEFIT ANALYSIS; EUROPE; HEALTH STATUS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS;

EID: 0347126349     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. de Koning HJ, Auvinen A, Berenguer Sanchez A et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 2002; 97: 237-44
2. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000; 21:2515-2725
3. Miller AB, Madalinska JB, Church T et al. Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial. Eur J Cancer 2001; 37:2154-60
4. Essink-Bot ML, de Koning HJ, Nijs HG, Kirkels WJ, van der Maas PJ, Schroder FH. Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 1998; 90: 925-31
5. Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001; 19: 1619-28
6. Brooks RG, Group E. EuroQoL: the current state of play. Health Policy 1996; 37: 53-72
7. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-108
8. de Haes JC, de Koning HJ, van Oortmarssen GJ, van Agt HM, de Bruyn AE, van Der Maas PJ. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 1991; 49: 538-44
9. Korfage IJ, Essink-Bot ML, Kirkels WJ, de Koning HJ, Schroder FH. Long-term health-related quality of life in localized prostate cancer. Quality Life Res 2002; 11: 623
10. Korfage IJ, Essink-Bot ML, Madalinska JB, Kirkels WJ, Litwin MS, de Koning HJ. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Quality Life Res 2003; 12: 459-64
11. Folkman S, Moskowitz JT. Positive affect and the other side of coping. Am Psychol 2000; 55: 647-54
12. Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med 1999; 48: 1531-48
13. Ganz PA, Litwin MS. Prostate cancer: the price of early detection. J Clin Oncol 2001; 19: 1587-8
14. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997
15. Donaldson C, Shackley P. Does 'process utility' exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med 1997; 44: 699-707
16. Birnie E, Bossuyt PMM, Bonsel GJ. Towards a framework for evaluation of non-health outcomes. Measurement and implications for cost-effectiveness analysis. In Monincx W, Birnie E. Fetal Monitoring at Home in High-risk Pregnancy.Thesis. Amsterdam: University of Amsterdam, 2000
17. Essink-Bot ML, Korfage IJ, de Koning HJ. The impact of radical prostatectomy and primary radiotherapy for localised prostate cancer on quality of life. In Newling D, Bangma C eds. Prostate and Renal Cancer, Benign Prostatic Hyperplasia, Erectile Dysfunction and Basic Research - an Update. London: The Parthenon Publishing Group, 2003 (ISBN 1-84214-196-1)
18. Stouthard MEA, Essink-Bot ML, Bonsel GJ, Group DDW. Disability weights for diseases - a modified protocol and results for a Western European region. Eur J Public Health 2000; 10: 24-30